A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression ...

Vaxxas has received a manufacturing licence from Australia’s Therapeutic Goods Administration (TGA) for its high-density ...

Milestone enables GMP manufacturing to accelerate clinical trials and transform global vaccine delivery BRISBANE, Australia ...

The Global Gene Expression Market is estimated to be valued at USD 16.56 Bn in 2025 and is expected to reach USD 23.61 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.2% from 2025 to ...

With an estimated more than 10 million cases, India accounts for nearly 20% of the global epilepsy burden. The number of ...

Most pockets in the human leukocyte antigen–group DR (HLA-DR) groove are shaped by clusters of polymorphic residues and, thus, have distinct chemical and size characteristics in different HLA-DR ...

Allergic sensitization follows distinct regional patterns, and molecular IgE profiling can reveal these profiles in detail. An international research team has now demonstrated both phenomena in a ...

Some of our most promising biotechs have taken part in a pre yuletide rush of clinical trial updates – and there is much to ...

With over a decade of experience architecting and operating large-scale cloud environments across AWS, Azure, and Google ...

Promising BioTech Vaxxas on Monday announced it will begin manufacturing its needle free vaccination patches in Brisbane for ...

A large study shows that routine H&E pathology slides contain rich spatial proteomic signals that can be decoded by AI to ...